313 related articles for article (PubMed ID: 17524236)
1. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L.
Sosa S; Pace R; Bornancin A; Morazzoni P; Riva A; Tubaro A; Della Loggia R
J Pharm Pharmacol; 2007 May; 59(5):703-9. PubMed ID: 17524236
[TBL] [Abstract][Full Text] [Related]
2. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
3. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methods for the exhaustive extraction of hypericins, flavonoids, and hyperforin from Hypericum perforatum L.
Smelcerovic A; Spiteller M; Zuehlke S
J Agric Food Chem; 2006 Apr; 54(7):2750-3. PubMed ID: 16569071
[TBL] [Abstract][Full Text] [Related]
5. Evidence for contributions of interactions of constituents to the anti-inflammatory activity of Hypericum perforatum.
Hammer KD; Birt DF
Crit Rev Food Sci Nutr; 2014; 54(6):781-9. PubMed ID: 24345048
[TBL] [Abstract][Full Text] [Related]
6. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse.
Cantoni L; Rozio M; Mangolini A; Hauri L; Caccia S
Toxicol Sci; 2003 Sep; 75(1):25-30. PubMed ID: 12857935
[TBL] [Abstract][Full Text] [Related]
7. Hypericum perforatum extract and hyperforin inhibit the growth of neurotropic parasite Toxoplasma gondii and infection-induced inflammatory responses of glial cells in vitro.
Shinjyo N; Nakayama H; Li L; Ishimaru K; Hikosaka K; Suzuki N; Yoshida H; Norose K
J Ethnopharmacol; 2021 Mar; 267():113525. PubMed ID: 33129946
[TBL] [Abstract][Full Text] [Related]
8. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
Wurglics M; Schubert-Zsilavecz M
Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452
[TBL] [Abstract][Full Text] [Related]
9. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prostaglandin E(2) production by anti-inflammatory hypericum perforatum extracts and constituents in RAW264.7 Mouse Macrophage Cells.
Hammer KD; Hillwig ML; Solco AK; Dixon PM; Delate K; Murphy PA; Wurtele ES; Birt DF
J Agric Food Chem; 2007 Sep; 55(18):7323-31. PubMed ID: 17696442
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies on Hypericum perforatum fractions and constituents.
Khan AU; Gilani AH; Najeeb-ur-Rehman
Pharm Biol; 2011 Jan; 49(1):46-56. PubMed ID: 20738215
[TBL] [Abstract][Full Text] [Related]
12. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
[TBL] [Abstract][Full Text] [Related]
13. St. John's wort: role of active compounds for its mechanism of action and efficacy.
Butterweck V; Schmidt M
Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
[TBL] [Abstract][Full Text] [Related]
14. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study.
Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC
J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952
[TBL] [Abstract][Full Text] [Related]
15. Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
Kraus B; Wolff H; Elstner EF; Heilmann J
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):541-53. PubMed ID: 20369228
[TBL] [Abstract][Full Text] [Related]
16. Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum.
Usai M; Leggio B; Grappi S; Nanni G; Gambarana C; Tolu P; Giachetti D; De Montis MG
Pharmacopsychiatry; 2003 Nov; 36(6):283-7. PubMed ID: 14663651
[TBL] [Abstract][Full Text] [Related]
17. Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats.
Perfumi M; Mattioli L; Cucculelli M; Massi M
J Psychopharmacol; 2005 Sep; 19(5):448-54. PubMed ID: 16166181
[TBL] [Abstract][Full Text] [Related]
18. Identification of anti-inflammatory constituents in Hypericum perforatum and Hypericum gentianoides extracts using RAW 264.7 mouse macrophages.
Huang N; Rizshsky L; Hauck C; Nikolau BJ; Murphy PA; Birt DF
Phytochemistry; 2011 Nov; 72(16):2015-23. PubMed ID: 21855951
[TBL] [Abstract][Full Text] [Related]
19. The antidepressant mechanism of Hypericum perforatum.
Mennini T; Gobbi M
Life Sci; 2004 Jul; 75(9):1021-7. PubMed ID: 15207650
[TBL] [Abstract][Full Text] [Related]
20. Fast high-performance liquid chromatographic analysis of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts.
Tolonen A; Hohtola A; Jalonen J
Phytochem Anal; 2003; 14(5):306-9. PubMed ID: 14516003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
